raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:33276

Kaposi sarcoma

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
Adult
Status
active

A rare vascular tumor that is characterized by human herpes virus 8 (HHV-8)-induced endothelial inflammatory neoplasm that develops with various clinically distinct settings, manifesting mostly as cutaneous lesions, or mucosal or visceral involvement.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enKaposi sarcoma
frSarcome de KaposiMaladie de Kaposi
deKaposi-Sarkom
esSarcoma de Kaposi
itSarcoma di Kaposi
nlKaposi-sarcoom
ptSarcoma de Kaposi
plMięsak Kaposiego
csKaposiho sarkom
ukСаркома Капоші
zh卡波西肉瘤
trKaposi sarkomu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM148000BTNTvalidated
ICD-10C46.0BTNTspecificvalidated
ICD-10C46.1BTNTspecificvalidated
ICD-10C46.2BTNTspecificvalidated
ICD-10C46.3BTNTspecificvalidated
ICD-10C46.7BTNTspecificvalidated
ICD-10C46.8BTNTspecificvalidated
ICD-10C46.9BTNTspecificvalidated
ICD-111C60.30BTNTspecificvalidated
ICD-111C61.30BTNTspecificvalidated
ICD-112B57Especificvalidated
ICD-112B57.0BTNTspecificvalidated
ICD-112B57.1BTNTspecificvalidated
ICD-112B57.2BTNTspecificvalidated
ICD-112B57.YBTNTattributedvalidated
ICD-11XH36A5Especificvalidated
MONDO0005055Evalidated
MeSHD012514Evalidated
UMLSC0036220Evalidated
GARD6814Evalidated
MedDRA10023284Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

26 records
TypeClassValueAreaQualificationValidationSource
Annual incidence1-9 / 1 000 0000.34 / 100 000EuropeValue and classValidated22033323[PMID]_RARECARE surveillance of rare cancers in Europe[OTHER]
Point prevalence1-9 / 100 000—EuropeClass onlyValidated22033323[PMID]_RARECARE surveillance of rare cancers in Europe[OTHER]
Lifetime Prevalence1-9 / 100 0002.11 / 100 000EuropeValue and classValidated22033323[PMID]_RARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.051 / 100 000AustriaValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.075 / 100 000BelgiumValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.099 / 100 000BulgariaValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.092 / 100 000Czech RepublicValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.065 / 100 000EstoniaValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.014 / 100 000FinlandValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.076 / 100 000GermanyValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.027 / 100 000NorwayValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.043 / 100 000PolandValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.05 / 100 000SlovakiaValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.056 / 100 000SloveniaValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence1-9 / 1 000 0000.133 / 100 000CroatiaValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence1-9 / 1 000 0000.111 / 100 000IrelandValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence1-9 / 1 000 0000.108 / 100 000LatviaValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence1-9 / 1 000 0000.112 / 100 000LithuaniaValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence1-9 / 1 000 0000.597 / 100 000MaltaValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence1-9 / 1 000 0000.915 / 100 000PortugalValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence1-9 / 1 000 0000.546 / 100 000SpainValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence1-9 / 1 000 0000.163 / 100 000SwitzerlandValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence1-9 / 1 000 0000.278 / 100 000NetherlandsValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence1-9 / 1 000 0000.192 / 100 000United KingdomValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence1-9 / 100 0001.363 / 100 000IcelandValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence1-9 / 100 0001.142 / 100 000ItalyValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

26 annotations · validated 2017-01-24
HPOTerm (as annotated by Orphanet)Diagnostic
Obligate (100%)
HP:0005353Recurrent herpes
Very frequent (99-80%)
HP:0002814Abnormality of the lower limb
HP:0001034Hypermelanotic macule
HP:0012733Macule
HP:0008069Neoplasm of the skin
Frequent (79-30%)
HP:0000479Abnormal retinal morphology
HP:0011024Abnormality of the gastrointestinal tract
HP:0001743Abnormality of the spleen
HP:0001298Encephalopathy
HP:0008940Generalized lymphadenopathy
HP:0001028Hemangioma
HP:0002721Immunodeficiency
HP:0005523Lymphoproliferative disorder
HP:0200034Papule
HP:0200036Skin nodule
Occasional (29-5%)
HP:0002088Abnormal lung morphology
HP:0001392Abnormality of the liver
HP:0002014Diarrhea
HP:0012378Fatigue
HP:0001945Fever
HP:0001004Lymphedema
HP:0011793Neoplasm by anatomical site
HP:0200035Skin plaque
HP:0000988Skin rash
HP:0005293Venous insufficiency
HP:0001824Weight loss

Run the differential on the 5 obligate / very frequent terms

Annotation source: 12705742[PMID]_11994760[PMID]

7

Sources for this card